Related Experiment Video
Updated: Feb 4, 2026

Discovering Middle Ear Anatomy by Transcanal Endoscopic Ear Surgery: A Dissection Manual
Published on: January 11, 2018
Effect of Mepolizumab on Middle Ear Disease and Hearing Outcomes in CRSwNP
Anne-Sophie Homøe1, Jens Tidemandsen2, Kasper Aanæs1
1Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Objective:
Otitis media with effusion (OME) is frequently observed in patients with severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)-yet it remains underrecognized. Both conditions are debilitating and may share type 2 inflammatory mechanisms. This study investigates the prevalence of OME (measured by tympanometry) in patients with CRSwNP and evaluates the effect of biologic treatment with mepolizumab, with or without combined FESS, on hearing outcomes as well as otologic symptoms.
Methods:
Secondary analysis of a randomized controlled trial (RCT) (n = 58) comparing FESS and mepolizumab versus mepolizumab alone in patients suffering from severe CRSwNP. Tympanometry, audiometry, and patient-reported outcomes (SNOT-22 and COMOT-15) were assessed at baseline and after 6 months.
Results:
At baseline, 22.8% (13/57) of patients had pathological tympanometry (OME), consistent with previous prevalence estimates. After 6 months, the proportion decreased to 14% (p = 0.07). No significant changes were observed in pure tone averages (PTA). In contrast, self-reported outcomes improved significantly, with reductions in both COMOT-15 and SNOT-22 scores (p < 0.05), independent of baseline tympanometry status.
Conclusion:
Mepolizumab treatment was associated with a trend toward reduced middle ear symptoms and significant improvement in self-reported otologic symptoms, supporting the concept of global type 2 airway inflammation and the clinical relevance of assessing ear disease in CRSwNP.
Insights
Mepolizumab treatment showed a trend toward reduced otitis media with effusion (OME) and improved hearing symptoms in severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) patients. This suggests a link between airway inflammation and ear conditions.
Area of Science:
- Otolaryngology
- Immunology
- Respiratory Medicine
Background:
- Otitis media with effusion (OME) is common in severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) but often overlooked.
- Both conditions are debilitating and may share underlying type 2 inflammatory pathways.
- Understanding the relationship between CRSwNP and OME is crucial for comprehensive patient management.
Purpose of the Study:
- To determine the prevalence of OME in severe CRSwNP patients using tympanometry.
- To evaluate the impact of mepolizumab, with or without Functional Endoscopic Sinus Surgery (FESS), on hearing and otologic symptoms in CRSwNP.
- To explore the role of biologic therapy in managing comorbid ear conditions in CRSwNP.
Main Methods:
- Secondary analysis of a randomized controlled trial (RCT) involving 58 severe CRSwNP patients.
- Comparison of mepolizumab alone versus mepolizumab combined with FESS.
- Assessment of tympanometry, audiometry, and patient-reported outcomes (SNOT-22, COMOT-15) at baseline and 6 months.
Main Results:
- Baseline OME prevalence was 22.8% (13/57) via tympanometry.
- After 6 months, OME prevalence decreased to 14% (p=0.07), with no significant change in pure tone averages (PTA).
- Significant improvements were noted in self-reported otologic symptoms (COMOT-15, SNOT-22 scores, p<0.05), irrespective of OME status.
Conclusions:
- Mepolizumab treatment demonstrated a trend towards reduced middle ear symptoms in CRSwNP patients.
- Significant improvement in patient-reported otologic symptoms was observed with mepolizumab.
- Findings support the concept of systemic type 2 inflammation and highlight the importance of evaluating ear health in CRSwNP management.
More Related Videos
10:27In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
03:49Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
Published on: October 11, 2024
Related Concept Videos
Hearing
Anatomy of the Ear
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...